Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Haas

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Arthritis & Rheumatology (Hoboken, N.J.)|April 3, 2018
IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic ArthritisVictoria L Arthur, Emily Shuldiner, Elaine F Remmers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2018
Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid ArthritisAnne Hinks, Miranda C Marion, Joanna Cobb, et al.
Autoimmunity Reviews|September 24, 2023
Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome - State of the art: Report of the 2nd international meeting at the Charité Fatigue CenterSophie Steiner, Annick Fehrer, Friederike Hoheisel, et al.
BMC Health Services Research|April 23, 2022
Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in GermanyMichael Kusch, Hildegard Labouvie, Vera Schiewer, et al.
Nature Genetics|April 23, 2013
Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritisAnne Hinks, Joanna Cobb, Miranda C Marion, et al.
Annals of the Rheumatic Diseases|December 9, 2016
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implicationsMichael J Ombrello, Victoria L Arthur, Elaine F Remmers, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2015
HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritisMichael J Ombrello, Elaine F Remmers, Ioanna Tachmazidou, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Arthritis & Rheumatology (Hoboken, N.J.)|April 3, 2018
IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic ArthritisVictoria L Arthur, Emily Shuldiner, Elaine F Remmers, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 10, 2018
Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid ArthritisAnne Hinks, Miranda C Marion, Joanna Cobb, et al.
Autoimmunity Reviews|September 24, 2023
Understanding, diagnosing, and treating Myalgic encephalomyelitis/chronic fatigue syndrome - State of the art: Report of the 2nd international meeting at the Charité Fatigue CenterSophie Steiner, Annick Fehrer, Friederike Hoheisel, et al.
BMC Health Services Research|April 23, 2022
Integrated, cross-sectoral psycho-oncology (isPO): a new form of care for newly diagnosed cancer patients in GermanyMichael Kusch, Hildegard Labouvie, Vera Schiewer, et al.
Nature Genetics|April 23, 2013
Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritisAnne Hinks, Joanna Cobb, Miranda C Marion, et al.
Annals of the Rheumatic Diseases|December 9, 2016
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implicationsMichael J Ombrello, Victoria L Arthur, Elaine F Remmers, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 25, 2015
HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritisMichael J Ombrello, Elaine F Remmers, Ioanna Tachmazidou, et al.
Pageof 11